FDA Grants Breakthrough Status to Schizophrenia Treatment FDA Grants Breakthrough Status to Schizophrenia Treatment Boehringer Ingelheim and Click Therapeutics receive FDA Breakthrough Device Designation for schizophrenia prescription digital therapeutic
Lameness horses collaboration Sleip app artificial intelligence Lameness horses collaboration Sleip app artificial intelligence The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.
FreVAX smartphone application piglet vaccination FreVAX smartphone application piglet vaccination New FreVAX™ smartphone application brings piglet vaccination to another level
First Translational Medicine Award awarded First Translational Medicine Award awarded The Award recognizes the research that has the highest translational potential
Blue internal teat sealant now in dairy mastitis portfolio Blue internal teat sealant now in dairy mastitis portfolio Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio
additional-investment-in-Lyon-Jonage additional-investment-in-Lyon-Jonage Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France
World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination
Brand of the Year Frontline pet parasiticides Brand of the Year Frontline pet parasiticides FRONTLINE® Wins Brand of the Year Award for the Third Time in a row
Partnership African animal trypanosomiasis Partnership African animal trypanosomiasis New partnership working on solutions to combat African animal trypanosomiasis
New vaccine against Bovine Respiratory Disease New vaccine against Bovine Respiratory Disease Boehringer Ingelheim’s Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against Bovine Respiratory Disease.
Nurjanahs Story Nurjanahs Story Nurjanah went from a sporty young woman to someone who no longer had the energy to do simple, everyday tasks. She was diagnosed with scleroderma.
FRONTLINE becomes Brand of the Year 2019-2020 FRONTLINE becomes Brand of the Year 2019-2020 FRONTLINE becomes ‘Brand of the Year’ 2019-2020 in World Branding Awards
Launch of Frontline flagship store on Tmall Launch of Frontline flagship store on Tmall Boehringer Ingelheim launches Frontline flagship store on Tmall to sell selling full range of pet parasiticides.
Positive opinion Ingelvac CircoFLEX and Ingelvac PRRSFLEX EU Positive opinion Ingelvac CircoFLEX and Ingelvac PRRSFLEX EU Boehringer Ingelheim receives positive opinion for the combined use of Ingelvac CircoFLEX® and Ingelvac PRRSFLEX EU® in the EU
Tips to help you start your patient advocacy journey Tips to help you start your patient advocacy journey Advocating for yourself as a patient can be daunting. Jeff Dunn, President of Union for International Cancer Control (UICC), shares some tips
Stem cell therapy for tendon and ligament injuries in horses Stem cell therapy for tendon and ligament injuries in horses A tendon or ligament injury can be devastating for horse owners, riders and trainers. Our new stem cell product improves the quality of healing.
FRONTLINE® becomes Brand of the Year 2021-22 FRONTLINE® becomes Brand of the Year 2021-22 FRONTLINE® becomes Brand of the Year 2021-2022 in World Branding Awards
Boehringer Ingelheim partners with GNA Biosolutions Boehringer Ingelheim partners with GNA Biosolutions Boehringer Ingelheim partners with GNA Biosolutions to develop African swine fever diagnostic test.
Winners of BVDzero Scholarship Programme Winners of BVDzero Scholarship Programme Boehringer Ingelheim announces winners of BVDzero Scholarship Programme
Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards announced. 10 top clinical cases will receive a total prize of 15,000 euros.
Vaccine prevent calf diarrhea Vaccine prevent calf diarrhea Fencovis® is the first vaccine to prevent calf diarrhea caused by E. coli F5 and bovine rotavirus and reduce severity of calf diarrhea caused by bovine coronavirus
PRRS vaccine celebrates 25 years in Europe PRRS vaccine celebrates 25 years in Europe Boehringer Ingelheim celebrates 25 years to combat PRRS in Europe
EMA authorization for Reprocyc ParvoFLEX EMA authorization for Reprocyc ParvoFLEX Boehringer Ingelheim obtains EMA authorization for Reprocyc® ParvoFLEX, a new porcine parvovirus vaccine